BeStock  

百时美施贵宝 BMY

美股市值排名 #155药品制造-综合癌症研究
$62.14 −$0.99 (-1.57%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $62.35 +0.34%
开盘$61.46
昨收$63.13
当日区间$61.32 – $63.06
成交量9.80M
市值$127.02B
市盈率(TTM)13.8
股息率4.06%

基本面

最新报告季度:Q3, ended Sep 2026

营收$13.07B+6.9% YoY
营业利润$4.40B+20.9% YoY
净利润$2.16B-1.5% YoY
摊薄每股收益$1.05-2.8% YoY
自由现金流$3.84B-36.0% YoY
经营现金流$4.18B

营收,近8个季度

$12.3BDec '24$11.2BMar '25$12.3BJun '25$12.2BSep '25$12.5BDec '25$11.5BMar '26$13.0BJun '26$13.1BSep '26

净利润,近8个季度

$76.0MDec '24$2.5BMar '25$1.3BJun '25$2.2BSep '25$1.1BDec '25$2.7BMar '26$3.3BJun '26$2.2BSep '26

各季度摊薄每股收益

0.04Dec '241.20Mar '250.64Jun '251.08Sep '250.53Dec '251.31Mar '261.62Jun '261.05Sep '26

各季度自由现金流

$4.1BDec '24$1.7BMar '25$3.6BJun '25$6.0BSep '25$1.6BDec '25$757.0MMar '26$3.1BJun '26$3.8BSep '26

年度营收

$42.5BFY20$46.4BFY21$46.2BFY22$45.0BFY23$48.3BFY24$48.2BFY25

盈利能力与资产负债表

毛利率69.2%
营业利润率29.2%
净利率18.5%
净资产收益率44.1%
资产收益率10.0%
投入资本回报率15.4%
流动比率1.59
负债/资产比率73.6%
现金及投资$12.58B
总负债$44.59B
净现金(净负债)-$32.01B
自由现金流/营收18.6%

营收构成

2026/Q3 季度

按业务线

  • Eliquis$4.69B 35.9%
  • Opdivo$2.37B 18.2%
  • Other$1.44B 11.0%
  • Orencia$983.00M 7.5%
  • Yervoy$793.00M 6.1%
  • Reblozyl$750.00M 5.7%
  • Other Growth products$731.00M 5.6%
  • Breyanzi$526.00M 4.0%
  • Camzyos$420.00M 3.2%
  • Opdualag$367.00M 2.8%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $13.07B $12.97B $11.49B $48.19B $12.50B
营业总收入 $13.07B $12.97B $11.49B $48.20B $12.50B
营业成本 $4.15B $3.73B $3.42B $13.94B $4.10B
毛利润 $8.92B $9.25B $8.07B $34.26B $8.41B
营业费用 $4.52B $5.22B $4.70B $20.54B $5.59B
销售及管理费用 $1.70B $1.83B $1.62B $7.27B $2.18B
研发费用 $2.37B $2.96B $2.65B $9.95B $2.59B
折旧、摊销与折耗 $458.00M $437.00M $437.00M $3.32B $826.00M
-折旧与摊销 $458.00M $437.00M $437.00M $3.32B $826.00M
营业利润 $4.40B $4.03B $3.37B $13.72B $2.81B
非经营性利息净收入(支出) -$403.00M -$407.00M -$411.00M -$1.89B -$432.00M
非经营性利息支出 $403.00M $407.00M $411.00M $1.89B $432.00M
其他收入(支出) -$1.46B $467.00M $284.00M -$2.50B -$909.00M
证券出售收益 $92.00M $215.00M $238.00M $510.00M -$18.00M
特殊收益(费用) -$1.76B $60.00M -$122.00M -$5.23B -$1.59B
-减:重组及并购费用 $1.76B $73.00M $118.00M $4.79B $1.59B
-减:其他特殊支出 $3.00M $5.00M $4.00M $434.00M $10.00M
-业务出售收益 $0.00 $138.00M – – –
其他非经营性收入(支出) $204.00M $192.00M $168.00M $2.21B $703.00M
税前利润 $2.54B $4.09B $3.24B $9.33B $1.47B
税费 $374.00M $770.00M $561.00M $2.27B $384.00M
净利润 $2.16B $3.32B $2.68B $7.06B $1.09B
持续经营利润 $2.16B $3.32B $2.68B $7.06B $1.09B
少数股东权益 $0.00 -$1.00M $1.00M $2.00M -$1.00M
归属母公司净利润 $2.16B $3.32B $2.68B $7.05B $1.09B
归属普通股股东净利润 $2.16B $3.32B $2.68B $7.05B $1.09B
基本每股收益 $1.06 $1.62 $1.31 $3.47 $0.53
摊薄每股收益 $1.05 $1.62 $1.31 $3.46 $0.53
每股股息 $0.63 $0.63 $0.63 $2.49 $0.63

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $88.77B $87.63B $86.48B $90.04B $90.04B
流动资产合计 $29.77B $28.58B $27.21B $29.39B $29.39B
现金及现金等价物与短期投资 $12.58B $11.07B $10.49B $10.67B $10.67B
-现金及现金等价物 $9.57B $8.72B $9.57B $10.21B $10.21B
-短期投资 $3.01B $2.35B $912.00M $464.00M $464.00M
应收款 $12.85B $13.00B $12.08B $14.53B $14.53B
-应收账款 $9.19B $9.08B $7.95B $9.59B $9.59B
-应收税款 $2.13B $2.34B $2.57B $2.92B $2.92B
-其他应收款 $1.53B $1.58B $1.57B $2.01B $2.01B
存货 $2.70B $2.74B $2.76B $2.69B $2.69B
其他流动资产 $1.63B $1.78B $1.88B $1.50B $1.50B
非流动资产合计 $59.00B $59.06B $59.27B $60.65B $60.65B
固定资产净值 $9.45B $9.28B $9.19B $9.13B $9.13B
-固定资产原值 $15.14B $14.83B $14.62B $14.42B $14.42B
-累计折旧 -$5.69B -$5.55B -$5.43B -$5.29B -$5.29B
投资及预付款 $2.32B $2.39B $2.24B $2.51B $2.51B
-持有至到期证券 $378.00M – – $15.00M $15.00M
-长期股权投资 $1.94B $1.99B $1.88B $2.10B $2.10B
商誉及其他无形资产 $38.90B $39.37B $40.23B $41.11B $41.11B
-商誉 $21.74B $21.74B $21.74B $21.75B $21.75B
-其他无形资产 $17.17B $17.63B $18.49B $19.35B $19.35B
设定受益养老金 $335.00M $332.00M $330.00M $330.00M $330.00M
一年以上递延资产 $5.88B $5.36B $5.18B $5.38B $5.38B
其他非流动资产 $2.11B $2.33B $2.10B $2.20B $2.20B
负债合计 $65.37B $65.32B $66.37B $71.53B $71.53B
流动负债合计 $18.75B $18.66B $19.16B $23.42B $23.42B
应付款 $6.64B $6.25B $6.43B $5.84B $5.84B
-应付账款 $4.63B $4.16B $4.23B $3.58B $3.58B
-应付税款合计 $727.00M $806.00M $909.00M $979.00M $979.00M
-应付股利 $1.29B $1.29B $1.29B $1.28B $1.28B
一年内应计费用 $589.00M $587.00M $507.00M $484.00M $484.00M
短期债务及融资租赁负债 $1.25B $1.23B $2.51B $2.46B $2.46B
-一年内到期债务 $1.03B $1.03B $2.31B $2.26B $2.26B
-一年内到期融资租赁负债 $220.00M $207.00M $199.00M $202.00M $202.00M
其他流动负债 $9.15B $9.71B $9.22B $13.07B $13.07B
非流动负债合计 $46.62B $46.66B $47.22B $48.12B $48.12B
长期应付账款及其他应付款 $900.00M $830.00M $1.31B $1.41B $1.41B
长期债务及融资租赁负债 $43.56B $43.82B $43.92B $44.68B $44.68B
-长期债务 $41.85B $42.09B $42.15B $42.85B $42.85B
-长期融资租赁负债 $1.71B $1.73B $1.77B $1.83B $1.83B
一年以上递延负债 $870.00M $885.00M $842.00M $878.00M $878.00M
员工福利 $299.00M $307.00M $317.00M $330.00M $330.00M
其他非流动负债 $984.00M $815.00M $824.00M $824.00M $824.00M
股东权益合计 $23.40B $22.32B $20.10B $18.51B $18.51B
股东权益 $23.40B $22.32B $20.07B $18.47B $18.47B
股本 $292.00M $292.00M $292.00M $292.00M $292.00M
-普通股 $292.00M $292.00M $292.00M $292.00M $292.00M
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $46.67B $46.50B $46.37B $46.39B $46.39B
留存收益 $21.19B $20.32B $18.29B $16.90B $16.90B
减:库存股 $43.47B $43.50B $43.52B $43.58B $43.58B
不影响留存收益的损益 -$1.28B -$1.29B -$1.37B -$1.52B -$1.52B
少数股东权益 $0.00 $0.00 $34.00M $33.00M $33.00M
-可供出售证券 – $397.00M $366.00M $396.00M $396.00M
其他权益权益 – $1.00M – – –

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $4.18B $3.39B $1.10B $14.16B $1.97B
持续经营经营活动现金流净额 $4.18B $3.39B $1.10B $14.16B $1.97B
持续经营净利润 $2.16B $3.32B $2.68B $7.06B $1.09B
持续经营损益 $16.00M -$256.00M -$168.00M -$1.45B -$475.00M
折旧、折耗与摊销 $626.00M $594.00M $594.00M $4.01B $977.00M
递延税款 -$510.00M -$195.00M $161.00M -$965.00M -$392.00M
其他非现金项目 $1.56B $1.00M $115.00M $4.30B $1.72B
营运资金变动 $193.00M -$624.00M -$2.83B -$455.00M -$1.65B
-应收款变动 -$95.00M -$1.18B $1.69B -$295.00M $19.00M
-存货变动 $133.00M -$36.00M $14.00M -$184.00M $71.00M
-应付账款及应计费用变动 $447.00M -$551.00M $596.00M -$6.00M -$414.00M
-其他营运资金变动 -$292.00M $1.15B -$5.13B $30.00M -$1.33B
投资活动现金流净额 -$2.10B -$1.61B -$131.00M -$4.13B -$1.46B
持续经营投资活动现金流净额 -$2.10B -$1.61B -$131.00M -$4.13B -$1.46B
资本支出 -$344.00M -$305.00M -$347.00M -$1.31B -$370.00M
业务购买及出售净额 -$1.12B $118.00M $247.00M -$2.87B -$1.43B
投资购置及出售净额 -$639.00M -$1.43B -$31.00M $52.00M $340.00M
筹资活动现金流 -$1.22B -$2.63B -$1.56B -$10.35B -$6.03B
持续经营筹资活动现金流净额 -$1.22B -$2.63B -$1.56B -$10.35B -$6.03B
债务发行及偿还净额 -$1.00M -$1.35B -$179.00M -$5.18B -$4.73B
已付现金股利 -$1.29B -$1.29B -$1.28B -$5.05B -$1.26B
股票期权行使所得 $66.00M $7.00M -$98.00M -$128.00M -$33.00M
期末现金余额 $9.57B $8.72B $9.58B $10.22B $10.22B
现金净变动 $855.00M -$851.00M -$587.00M -$324.00M -$5.51B
期初现金余额 $8.72B $9.58B $10.22B $10.35B $15.73B
汇率变动影响 -$3.00M -$10.00M -$48.00M $195.00M $5.00M
自由现金流 $3.84B $3.09B $757.00M $12.85B $1.60B
普通股发行净额 – – – $0.00 –

讨论区

暂无评论——快来第一个聊聊 BMY。

发表评论

Scroll to Top